Details
Stereochemistry | ACHIRAL |
Molecular Formula | C12H14N4O4S |
Molecular Weight | 310.329 |
Optical Activity | NONE |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
COC1=CC(NS(=O)(=O)C2=CC=C(N)C=C2)=NC(OC)=N1
InChI
InChIKey=ZZORFUFYDOWNEF-UHFFFAOYSA-N
InChI=1S/C12H14N4O4S/c1-19-11-7-10(14-12(15-11)20-2)16-21(17,18)9-5-3-8(13)4-6-9/h3-7H,13H2,1-2H3,(H,14,15,16)
DescriptionSources: http://drug.report/Sulfadimethoxine/Curator's Comment: description was created based on several sources, including
http://www.fda.gov/animalveterinary/products/approvedanimaldrugproducts/foiadrugsummaries/ucm118359.htm; http://www.ema.europa.eu/docs/en_GB/document_library/Report/2013/02/WC500138474.pdf
Sources: http://drug.report/Sulfadimethoxine/
Curator's Comment: description was created based on several sources, including
http://www.fda.gov/animalveterinary/products/approvedanimaldrugproducts/foiadrugsummaries/ucm118359.htm; http://www.ema.europa.eu/docs/en_GB/document_library/Report/2013/02/WC500138474.pdf
Sulfadimethoxine is a sulfonamide antibacterial used to treat many infections including treatment of respiratory, urinary tract, enteric, and soft tissue infections. It is most frequently used in veterinary medicine, although it is approved in some countries for use in humans. Sulfadimethoxine inhibits bacterial synthesis of folic acid (pteroylglutamic acid) from para-aminobenzoic acid. Sulfadimethoxine is approved in Russia for use in humans, including children, and has been successfully used there for more than 35 years and is available as an over-the-counter drug manufactured by a number of Russian pharmaceutical companies. In USA and Europe sulfadimethoxine is approved in a veterinary medicinal products. ANADA was approved by FDA in US in 1997 as an Over the Counter medicine for treatment of bovine respiratory disease complex (shipping fever complex) and bacterial pneumonia associated with Pasteurella Spp. Sensitive to sulfadimethoxine; necrotic pododermatitis (foot rot) and calf diphtheria caused by Fusobacterium necrophorum (Sphaerophorus necrophorus) sensitive to sulfadimethoxine. Bioequivalence for this generic animal drug, Sulfadimethoxine Injection 40%, was established by demonstration of chemical equivalence to the pioneer product, Hoffmann-La Roche's Albon® Injection 40% (NADA 041-245).
Originator
Sources: https://www.ncbi.nlm.nih.gov/pubmed/13665342
Curator's Comment: Sulfadimethoxine (madribon) was developed in the late 1950s. # Roche Laboratories, Division of Hoffman-La Roche Inc
Approval Year
Targets
Primary Target | Pharmacology | Condition | Potency |
---|---|---|---|
Target ID: map00790 Sources: https://www.ncbi.nlm.nih.gov/pubmed/?term=23859210 |
Conditions
Condition | Modality | Targets | Highest Phase | Product |
---|---|---|---|---|
Curative | ANADA Approved UseFor treatment of bovine respiratory disease complex (shipping fever complex) and bacterial pneumonia associated with Pasteurella Spp. sensitive to sulfadimethoxine; necrotic pododermatitis (foot rot) and calf diphtheria caused by Fusobacterium necrophorum (Sphaerophorus necrophorus) sensitive to sulfadimethoxine Launch Date1997 |
|||
Curative | ANADA Approved UseFor treatment of bovine respiratory disease complex (shipping fever complex) and bacterial pneumonia associated with Pasteurella Spp. sensitive to sulfadimethoxine; necrotic pododermatitis (foot rot) and calf diphtheria caused by Fusobacterium necrophorum (Sphaerophorus necrophorus) sensitive to sulfadimethoxine Launch Date1997 |
Doses
Dose | Population | Adverse events |
---|---|---|
500 mg 2 times / day multiple, oral Studied dose Dose: 500 mg, 2 times / day Route: oral Route: multiple Dose: 500 mg, 2 times / day Sources: Page: p.344, 345 |
unhealthy, 20 n = 1 Health Status: unhealthy Condition: Acne Age Group: 20 Sex: F Population Size: 1 Sources: Page: p.344, 345 |
Disc. AE: Cholestatic jaundice... AEs leading to discontinuation/dose reduction: Cholestatic jaundice (mild) Sources: Page: p.344, 345 |
500 mg 1 times / day multiple, oral Studied dose Dose: 500 mg, 1 times / day Route: oral Route: multiple Dose: 500 mg, 1 times / day Sources: Page: p.230 |
unhealthy n = 24 Health Status: unhealthy Condition: Urinary tract infections| Pyuria| Pyelonephritis| Cystitis Sex: M+F Population Size: 24 Sources: Page: p.230 |
AEs
AE | Significance | Dose | Population |
---|---|---|---|
Cholestatic jaundice | mild Disc. AE |
500 mg 2 times / day multiple, oral Studied dose Dose: 500 mg, 2 times / day Route: oral Route: multiple Dose: 500 mg, 2 times / day Sources: Page: p.344, 345 |
unhealthy, 20 n = 1 Health Status: unhealthy Condition: Acne Age Group: 20 Sex: F Population Size: 1 Sources: Page: p.344, 345 |
PubMed
Title | Date | PubMed |
---|---|---|
Anti-cryptosporidial drug activity screened with an immunosuppressed rat model. | 1991 Nov-Dec |
|
Effects of sodium chlorate on antibiotic resistance in Escherichia coli O157:H7. | 2004 Spring |
|
The jaundiced gunn rat model of auditory neuropathy/dyssynchrony. | 2005 Dec |
|
Simultaneous extraction and analysis of 11 tetracycline and sulfonamide antibiotics in influent and effluent domestic wastewater by solid-phase extraction and liquid chromatography-electrospray ionization tandem mass spectrometry. | 2005 Dec 2 |
|
[Qualification and quantification of 10 sulfonamides in animal feedstuff by high performance liquid chromatography-electrospray tandem mass spectrometry]. | 2005 Jul |
|
Confirmation of sulfamethazine, sulfathiazole, and sulfadimethoxine residues in condensed milk and soft-cheese products by liquid chromatography/tandem mass spectrometry. | 2005 May-Jun |
|
[Determination of residual sulfonamides in meat by high performance liquid chromatography with solid-phase extraction]. | 2005 Nov |
|
Determination of pKa values by capillary zone electrophoresis with a dynamic coating procedure. | 2005 Nov |
|
Actinomyces naeslundii infection in an African hedgehog (Atelerix albiventris) with mandibular osteomyelitis and cellulitis. | 2005 Oct 8 |
|
Simultaneous determination of 16 sulfonamides in honey by liquid chromatography/tandem mass spectrometry. | 2005 Sep-Oct |
|
Sex-specific regional brain bilirubin content in hyperbilirubinemic Gunn rat pups. | 2006 |
|
Evaluation of changes in antimicrobial susceptibility patterns of Pasteurella multocida subsp multocida isolates from pigs in Spain in 1987-1988 and 2003-2004. | 2006 Apr |
|
Multiresidue determination of sulfonamides in edible catfish, shrimp and salmon tissues by high-performance liquid chromatography with postcolumn derivatization and fluorescence detection. | 2006 Aug 18 |
|
Biliverdin-induced brainstem auditory evoked potential abnormalities in the jaundiced Gunn rat. | 2006 Aug 30 |
|
Characterization of bacterial susceptibility isolates in sixteen dairy farms in Taiwan. | 2006 Dec |
|
Oxidation of sulfonamide antimicrobials by ferrate(VI) [Fe(VI)O4(2-)]. | 2006 Dec 1 |
|
Prevalence and characterization of Escherichia coli O157 isolates from Minnesota dairy farms and county fairs. | 2006 Feb |
|
Comparison of enhancing effects of different goitrogen treatments in combination with beta-estradiol-3-benzoate for establishing a rat two-stage thyroid carcinogenesis model to detect modifying effects of estrogenic compounds. | 2006 Jan |
|
Degradation kinetics of manure-derived sulfadimethoxine in amended soil. | 2006 Jan 11 |
|
Oxidation of sulfonamides, macrolides, and carbadox with free chlorine and monochloramine. | 2006 Jul |
|
Calculated in vivo free bilirubin levels in the central nervous system of Gunn rat pups. | 2006 Jul |
|
Absence of in vivo genotoxic potential and tumor initiation activity of kojic acid in the rat thyroid. | 2006 May 15 |
|
Sulfadimethoxine degradation kinetics in manure as affected by initial concentration, moisture, and temperature. | 2006 Nov-Dec |
|
Application of capillary zone electrophoresis with large-volume sample stacking to the sensitive determination of sulfonamides in meat and ground water. | 2006 Oct |
|
Determination of antimicrobials in sludge from infiltration basins at two artificial recharge plants by pressurized liquid extraction-liquid chromatography-tandem mass spectrometry. | 2006 Oct 13 |
|
Determination of sulfonamide antibiotics in wastewater: a comparison of solid phase microextraction and solid phase extraction methods. | 2006 Oct 27 |
|
Occurrence of sulfonamide antimicrobials in private water wells in Washington County, Idaho, USA. | 2006 Sep |
|
Exhaustive extraction of sulfonamide antibiotics from aged agricultural soils using pressurized liquid extraction. | 2006 Sep 22 |
|
Observational study of hepatic cytochrome P-450 protein expression and activity in summer flounder (Paralichtys dentatus) after combination ormetoprim-sulfadimethoxine treatment. | 2007 |
|
NMDA channel antagonist MK-801 does not protect against bilirubin neurotoxicity. | 2007 |
|
Minocycline blocks acute bilirubin-induced neurological dysfunction in jaundiced Gunn rats. | 2007 |
|
In-vitro antifungal activities of sulfa drugs against clinical isolates of Aspergillus and Cryptococcus species. | 2007 |
|
Aquatic toxicity of acetaminophen, carbamazepine, cimetidine, diltiazem and six major sulfonamides, and their potential ecological risks in Korea. | 2007 Apr |
|
Performance of blue-yellow screening test for antimicrobial detection in ovine milk. | 2007 Dec |
|
Simultaneous determination of 17 sulfonamides and the potentiators ormetoprim and trimethoprim in salmon muscle by liquid chromatography with tandem mass spectrometry detection. | 2007 Jan-Feb |
|
Determination of residues of sulphonamide in eggs and laying hens. | 2007 Jul |
|
Use of sulfadimethoxine in intensive calf farming: evaluation of transfer to stable manure and soil. | 2007 Jun |
|
Depression of T cell-mediated immunity reduces sulfadimethoxine-induced capsular inflammation and inhibits associated development of invasive thyroid follicular cell carcinomas in rats. | 2007 Mar |
|
Development of an immunochromatographic lateral-flow test strip for rapid detection of sulfonamides in eggs and chicken muscles. | 2007 Mar 21 |
|
Validation of an analytical method to determine sulfamides in kidney by HPLC-DAD and PARAFAC2 with first-order derivative chromatograms. | 2007 Mar 28 |
|
Determination of 10 sulfonamide residues in meat samples by liquid chromatography with ultraviolet detection. | 2007 Mar-Apr |
|
Cytotoxicity is predicted by unbound and not total bilirubin concentration. | 2007 Nov |
|
Analytical methods for multiresidue determination of sulfonamides and trimethoprim in meat and ground water samples by CE-MS and CE-MS/MS. | 2007 Nov |
|
Determination of sulphonamides in animal tissues by high performance liquid chromatography with pre-column derivatization of 9-fluorenylmethyl chloroformate. | 2007 Nov |
|
Efficacy of eleven antimicrobials against a gregarine parasite (Apicomplexa: Protozoa). | 2007 Nov 12 |
|
Organic solvents-free technique for determining sulfadimethoxine and its metabolites in chicken meat. | 2007 Nov 16 |
|
[Simultaneous determination of nine sulfonamide residues in milk using solid phase extraction and high performance liquid chromatography]. | 2007 Sep |
|
Antimicrobial susceptibility of Shiga toxin-producing Escherichia coli isolated from organic dairy farms, conventional dairy farms, and county fairs in Minnesota. | 2007 Summer |
|
Salmonella in healthy pigs: prevalence, serotype diversity and antimicrobial resistance observed during 1998-1999 and 2004-2005 in Japan. | 2008 Aug |
|
Diagnosis and treatment of Eimeria macusaniensis in an adult alpaca with signs of colic. | 2009 Mar |
Patents
Sample Use Guides
In Vivo Use Guide
Sources: http://www.fda.gov/animalveterinary/products/approvedanimaldrugproducts/foiadrugsummaries/ucm118359.htm
Curator's Comment: ANADA, a generic product and the pioneer product Albon have identical indications for use in cattle.
25 mg/lb initial dose of ANADA followed by 12.5 mg/lb for maintenance doses every 24 hours.
Route of Administration:
Intravenous
In Vitro Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/21908365
Sulfadimethoxine MIC of <256 mg/ml was determined against Arcanobacterium pyogenes isolated from the lungs of white-tailed deer (Odocoileus virginianus) with pneumonia
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
CFR |
21 CFR 520.2220
Created by
admin on Fri Dec 15 15:02:36 GMT 2023 , Edited by admin on Fri Dec 15 15:02:36 GMT 2023
|
||
|
WHO-VATC |
QJ01EQ59
Created by
admin on Fri Dec 15 15:02:36 GMT 2023 , Edited by admin on Fri Dec 15 15:02:36 GMT 2023
|
||
|
CFR |
21 CFR 556.640
Created by
admin on Fri Dec 15 15:02:36 GMT 2023 , Edited by admin on Fri Dec 15 15:02:36 GMT 2023
|
||
|
CFR |
21 CFR 520.2220B
Created by
admin on Fri Dec 15 15:02:36 GMT 2023 , Edited by admin on Fri Dec 15 15:02:36 GMT 2023
|
||
|
WHO-VATC |
QP51AG02
Created by
admin on Fri Dec 15 15:02:36 GMT 2023 , Edited by admin on Fri Dec 15 15:02:36 GMT 2023
|
||
|
WHO-VATC |
QJ01EW09
Created by
admin on Fri Dec 15 15:02:36 GMT 2023 , Edited by admin on Fri Dec 15 15:02:36 GMT 2023
|
||
|
CFR |
21 CFR 520.2220C
Created by
admin on Fri Dec 15 15:02:36 GMT 2023 , Edited by admin on Fri Dec 15 15:02:36 GMT 2023
|
||
|
WHO-VATC |
QJ01EQ09
Created by
admin on Fri Dec 15 15:02:36 GMT 2023 , Edited by admin on Fri Dec 15 15:02:36 GMT 2023
|
||
|
WHO-ATC |
J01ED01
Created by
admin on Fri Dec 15 15:02:36 GMT 2023 , Edited by admin on Fri Dec 15 15:02:36 GMT 2023
|
||
|
CFR |
21 CFR 520.2220D
Created by
admin on Fri Dec 15 15:02:36 GMT 2023 , Edited by admin on Fri Dec 15 15:02:36 GMT 2023
|
||
|
CFR |
21 CFR 520.2220A
Created by
admin on Fri Dec 15 15:02:36 GMT 2023 , Edited by admin on Fri Dec 15 15:02:36 GMT 2023
|
||
|
CFR |
21 CFR 522.2220
Created by
admin on Fri Dec 15 15:02:36 GMT 2023 , Edited by admin on Fri Dec 15 15:02:36 GMT 2023
|
||
|
CFR |
21 CFR 520.2220E
Created by
admin on Fri Dec 15 15:02:36 GMT 2023 , Edited by admin on Fri Dec 15 15:02:36 GMT 2023
|
||
|
NCI_THESAURUS |
C29739
Created by
admin on Fri Dec 15 15:02:36 GMT 2023 , Edited by admin on Fri Dec 15 15:02:36 GMT 2023
|
||
|
CFR |
21 CFR 520.2220F
Created by
admin on Fri Dec 15 15:02:36 GMT 2023 , Edited by admin on Fri Dec 15 15:02:36 GMT 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
100000083246
Created by
admin on Fri Dec 15 15:02:36 GMT 2023 , Edited by admin on Fri Dec 15 15:02:36 GMT 2023
|
PRIMARY | |||
|
32161
Created by
admin on Fri Dec 15 15:02:36 GMT 2023 , Edited by admin on Fri Dec 15 15:02:36 GMT 2023
|
PRIMARY | |||
|
10172
Created by
admin on Fri Dec 15 15:02:36 GMT 2023 , Edited by admin on Fri Dec 15 15:02:36 GMT 2023
|
PRIMARY | RxNorm | ||
|
204-523-7
Created by
admin on Fri Dec 15 15:02:36 GMT 2023 , Edited by admin on Fri Dec 15 15:02:36 GMT 2023
|
PRIMARY | |||
|
CHEMBL62193
Created by
admin on Fri Dec 15 15:02:36 GMT 2023 , Edited by admin on Fri Dec 15 15:02:36 GMT 2023
|
PRIMARY | |||
|
757860
Created by
admin on Fri Dec 15 15:02:36 GMT 2023 , Edited by admin on Fri Dec 15 15:02:36 GMT 2023
|
PRIMARY | |||
|
1626001
Created by
admin on Fri Dec 15 15:02:36 GMT 2023 , Edited by admin on Fri Dec 15 15:02:36 GMT 2023
|
PRIMARY | |||
|
840
Created by
admin on Fri Dec 15 15:02:36 GMT 2023 , Edited by admin on Fri Dec 15 15:02:36 GMT 2023
|
PRIMARY | |||
|
DTXSID1023607
Created by
admin on Fri Dec 15 15:02:36 GMT 2023 , Edited by admin on Fri Dec 15 15:02:36 GMT 2023
|
PRIMARY | |||
|
SULFADIMETHOXINE
Created by
admin on Fri Dec 15 15:02:36 GMT 2023 , Edited by admin on Fri Dec 15 15:02:36 GMT 2023
|
PRIMARY | |||
|
30CPC5LDEX
Created by
admin on Fri Dec 15 15:02:36 GMT 2023 , Edited by admin on Fri Dec 15 15:02:36 GMT 2023
|
PRIMARY | |||
|
SUB10698MIG
Created by
admin on Fri Dec 15 15:02:36 GMT 2023 , Edited by admin on Fri Dec 15 15:02:36 GMT 2023
|
PRIMARY | |||
|
DB06150
Created by
admin on Fri Dec 15 15:02:36 GMT 2023 , Edited by admin on Fri Dec 15 15:02:36 GMT 2023
|
PRIMARY | |||
|
30CPC5LDEX
Created by
admin on Fri Dec 15 15:02:36 GMT 2023 , Edited by admin on Fri Dec 15 15:02:36 GMT 2023
|
PRIMARY | |||
|
683544
Created by
admin on Fri Dec 15 15:02:36 GMT 2023 , Edited by admin on Fri Dec 15 15:02:36 GMT 2023
|
PRIMARY | |||
|
122-11-2
Created by
admin on Fri Dec 15 15:02:36 GMT 2023 , Edited by admin on Fri Dec 15 15:02:36 GMT 2023
|
PRIMARY | |||
|
2501
Created by
admin on Fri Dec 15 15:02:36 GMT 2023 , Edited by admin on Fri Dec 15 15:02:36 GMT 2023
|
PRIMARY | |||
|
D013412
Created by
admin on Fri Dec 15 15:02:36 GMT 2023 , Edited by admin on Fri Dec 15 15:02:36 GMT 2023
|
PRIMARY | |||
|
m10307
Created by
admin on Fri Dec 15 15:02:36 GMT 2023 , Edited by admin on Fri Dec 15 15:02:36 GMT 2023
|
PRIMARY | Merck Index | ||
|
C76975
Created by
admin on Fri Dec 15 15:02:36 GMT 2023 , Edited by admin on Fri Dec 15 15:02:36 GMT 2023
|
PRIMARY | |||
|
5323
Created by
admin on Fri Dec 15 15:02:36 GMT 2023 , Edited by admin on Fri Dec 15 15:02:36 GMT 2023
|
PRIMARY |
ACTIVE MOIETY
SALT/SOLVATE (PARENT)